On Friday the IBEC-managed Spanish Nanotechnology Platform, NanoMed Spain, co-hosted the fifth edition of Nano World Cancer Day, a global initiative organized as part of World Cancer Day.
It’s the third year running that the platform has hosted the conference, which took place at the PCB and was opened by IBEC/NanoMed Spain’s Josep Samitier, who also gave a presentation about the platform.
The latest innovations in nanomedicine for cancer were presented and discussed in front of an audience of more than 90 researchers, clinicians, students and industry professionals, as well as journalists.
The other speakers were Ana Roda of the Fundación Científica de la Asociación Española contra el Cáncer (AECC); Salvador Borrós and Anna Cascante of SAGETIS Biotech; IBEC’s Pere Roca-Cusachs and Joan Montero; and Jaume Mora, Scientific Director of onco-hematology at Hospital Sant Joan de Déu. They presented various new advances in the field and what they may imply in terms of new opportunities in diagnostics and therapies against cancer.
Austria, France, Iceland, Ireland, Israel, Italy, Portugal, Spain, Turkey and the United Kingdom were also holding events simultaneously on Nano World Cancer Day, each attended by nanomedicine experts from each country and from different backgrounds including researchers, physicians, oncologists and entrepreneurs.
Nano World Cancer Day was first held in 2013 and is organized at the European level by the European Technology Platform for Nanomedicine (ETPN) under European project ENATRANS (Enabling Nanomedicine Translation), and locally by the different components of the ETPN in each country.